Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Lymphoma 306Lymphoma, Follicular 268Lymphoma, Non-Hodgkin 170Leukemia 138Hodgkin Disease 135Multiple Myeloma 130Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Large B-Cell, Diffuse 108Leukemia, Myeloid, Acute 98Neoplasms 83Lymphoma, Mantle-Cell 70Burkitt Lymphoma 70Myelodysplastic Syndromes 64Breast Neoplasms 62Lymphoma, T-Cell, Cutaneous 60Lymphoma, B-Cell, Marginal Zone 59Myeloproliferative Disorders 50Mycosis Fungoides 50Motor Activity 49Lymphoma, Large-Cell, Immunoblastic 47Sezary Syndrome 44Neoplasms, Plasma Cell 42Hematologic Neoplasms 41Dementia 41Primary Myelofibrosis 39Leukemia, Myeloid, Chronic-Phase 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 38Recurrence 37

Interventions

Deferoxamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Iron Overload × Lymphoid × Clear all
NCT00658411 2013-04-09

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase NA Terminated
5 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Iron Overload, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡